UNSPSC 51282500: First generation cephalosporins

This classification denotes the original and first variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term CEPHALOSPORIN.

UNSPSC 51282500 First generation cephalosporins is a Class code that in recent state and local activity covers a broader range of medical and pharmaceutical supplies than the code name suggests, including emergency medical equipment, over-the-counter products, and generic pharmaceuticals sourced through state purchasing cooperatives and health agencies. State and local governments are using this code to procure medical consumables for fire departments, emergency response divisions, and community health programs, as well as to establish framework contracts for pharmaceutical distribution through authorized wholesalers. Issuing bodies include city procurement departments (Tampa), county health agencies (Seminole County), state health and human services commissions (Texas HHS), and state purchasing cooperatives (Minnesota). The purchasing model spans direct competitive bids for specific quantities of emergency supplies, cooperative framework agreements for multi-state generic pharmaceutical distribution, and exploratory requests for information to shape future pharmacy benefit procurement strategies.

Recent activity concentrates in Florida, Texas, and Minnesota. The City of Tampa Fire Department Rescue Division released an IFB (26-P-00145) due March 13, 2026, for 169 line items of medical and first aid supplies with an estimated contract value of $700,000, structured as a sheltered small local business enterprise opportunity with a 5 percent bid discount. Seminole County, Florida posted IFB 60459723LAS due July 26, 2023, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries. The Minnesota Department of Administration issued an RFP through the Multistate Cooperative Purchasing Alliance (MMCAP) due March 26, 2026, seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities in Minnesota and Oregon through three authorized wholesalers. The Texas Health and Human Services Commission issued an exploratory RFI (HHS0017013) in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling intent to shift pharmacy procurement models away from traditional PBM and GPO channels.